EU agency: Increase in manufacturing capacity for vaccine from AstraZeneca

BRUSSELS, Dec 1 (KUNA) -- The European Medicines Agency (EMA) Wednesday announced the approval of a new site to manufacture Vaxzevria (previously COVID-19 Vaccine AstraZeneca) finished product. The site is located in Leverkusen, Germany, it said in a statement.
In addition to this new manufacturing facility, the EMA also gave a positive opinion to scale up manufacturing to triple the batch size of finished product at a site in West Chester Township, Ohio, the United States.
These changes are expected to support the continued supply of Vaxzevria in the European Union and donations to third countries through the COVID-19 Vaccines Global Access (COVAX) initiative, it added. (end) nk.rk